Nalaganje...

Eslicarbazepine acetate add‐on therapy for drug‐resistant focal epilepsy

BACKGROUND: This is an update of a review first published in 2011, and last updated in 2017. Most people with epilepsy have a good prognosis, but up to 30% of people continue to have seizures despite several regimens of antiepileptic drugs. In this review, we summarized the current evidence regardin...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cochrane Database Syst Rev
Main Authors: Chang, Xian-Chao, Yuan, Hai, Wang, Yi, Xu, Hui-Qin, Hong, Wen-Ke, Zheng, Rong-Yuan
Format: Artigo
Jezik:Inglês
Izdano: John Wiley & Sons, Ltd 2021
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8218144/
https://ncbi.nlm.nih.gov/pubmed/34155624
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD008907.pub4
Oznake: Označite
Brez oznak, prvi označite!